Latest News | Dr Reddy's Launches Fluphenazine Hydrochloride Tablets in US
Get latest articles and stories on Latest News at LatestLY. Drug major Dr Reddy's Laboratories on Thursday said it has launched Fluphenazine Hydrochloride tablets, used for management of manifestations of psychotic disorders, in the US market.
New Delhi, Feb 18 (PTI) Drug major Dr Reddy's Laboratories on Thursday said it has launched Fluphenazine Hydrochloride tablets, used for management of manifestations of psychotic disorders, in the US market.
The product is a therapeutic equivalent generic version of Prolixin tablets approved by the US Food and Drug Administration (USFDA).
In a regulatory filing, Dr Reddy's laboratories announced the launch of Fluphenazine Hydrochloride tablets in the US.
Quoting IQVIA Health data, Dr Reddy's said Prolixin brand and generic had US sales of approximately USD 134 million for the most recent 12 months ending in December 2020.
Dr Reddy's Fluphenazine Hydrochloride tablets, USP, are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
Shares of Dr Reddy's Laboratories were trading 0.88 per cent higher at Rs 4,642.25 apiece on BSE.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)